Catch me if you can: Targeting the mitochondrial permeability transition pore in myocardial infarction

Cell Death and Differentiation

Volumn 23, Issue 1, 2016, Pages 1-2

  Linkermann, A ^a   Konstantinidis, K ^b   Kitsis, R N ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CREATINE KINASE; CYCLOPHILIN D; CYCLOSPORIN A; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TROPONIN I; CYCLOPHILIN; CYCLOSPORIN; ENZYME INHIBITOR;

ADVERSE OUTCOME; CARDIOVASCULAR MAGNETIC RESONANCE; CREATINE KINASE BLOOD LEVEL; EDITORIAL; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PERMEABILITY; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FEMALE; HEART VENTRICLE REMODELING; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION;

CYCLOPHILINS; CYCLOSPORINE; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; VENTRICULAR REMODELING;

EID: 84949512340     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.151     Document Type: Editorial

References (15)

1. Konstantinidis K, Whelan RS, Kitsis RN. Arterioscler Thromb Vasc Biol 2012; 32: 1552-1562.
2. American College of Emergency., et al. J Am Coll Cardiol 2013; 61: e78-140.
3. Ong SB., et al. J Mol Cell Cardiol 2015; 78: 23-34.
4. Cung TT., et al. N Engl J Med 2015; 373: 1021-1031.
5. Miller TD., et al. Circulation 1995; 92: 334-341.
6. Vanden Berghe T., et al. Nat Rev Mol Cell Biol 2014; 15: 135-147.
7. Bernardi P., et al. Physiol Rev 2015; 95: 1111-1155.
8. Nakagawa T., et al. Nature 2005; 434: 652-658.
9. Baines CP., et al. Nature 2005; 434: 658-662.
10. Mewton N., et al. J Am Coll Cardiol 2010; 55: 1200-1205.
11. Piot C., et al. N Engl J Med 2008; 359: 473-481.
12. Lim WY, Messow CM, Berry C. Br J Pharmacol 2012; 165: 2034-2043.
13. Cereghetti GM., et al. Proc Natl Acad Sci USA 2008; 105: 15803-15808.
14. Whelan RS., et al. Proc Natl Acad Sci USA 2012; 109: 6566-6571.
15. Linkermann A., et al. Proc Natl Acad Sci USA 2013; 110: 12024-12029.